Objective: This study reassessed adolescents and young adults (15-22 years old) who received individually tailored multimodal treatment for ADHD (behavior therapy and/or stimulant medication) during childhood 6 to 12 years after treatment (M = 8.8 years, SD = 1.6). Method: All participants (N = 75) provided information about their social functioning. Most parents (83%) completed behavior rating scales. Results: Participants demonstrated significant improvement in behavior during the follow-up period with effect sizes on ADHD symptoms of d = 1.2 and 68% of the former patients in the normal range at follow-up. Participants reported elevated rates of grade retention (51%), school dropout (13%), special education service use (17%), school change (47%), and conviction (16%), but few were unemployed (4%). Conclusion: This study provides evidence that the effects of individually tailored multimodal treatment for ADHD in childhood are maintained into adolescence and young adulthood. No hints could be found that continued medication results in a more favorable long-term outcome.
Objective: This study reassessed adolescents and young adults (15-22 years old) who received individually tailored multimodal treatment for ADHD (behavior therapy and/or stimulant medication) during childhood 6 to 12 years after treatment (M = 8.8 years, SD = 1.6). Method: All participants (N = 75) provided information about their social functioning. Most parents (83%) completed behavior rating scales. Results:Participants demonstrated significant improvement in behavior during the follow-up period with effect sizes on ADHD symptoms of d = 1.2 and 68% of the former patients in the normal range at follow-up. Participants reported elevated rates of grade retention (51%), school dropout (13%), special education service use (17%), school change (47%), and conviction (16%), but few were unemployed (4%). Conclusion: This study provides evidence that the effects of individually tailored multimodal treatment for ADHD in childhood are maintained into adolescence and young adulthood. No hints could be found that continued medication results in a more favorable long-term outcome.
Entities:
Keywords:
ADHD; behavior therapy; long-term effects; medical management; multimodal treatment
Authors: Julia Geissler; Thomas Jans; Tobias Banaschewski; Katja Becker; Tobias Renner; Daniel Brandeis; Manfred Döpfner; Christina Dose; Christopher Hautmann; Martin Holtmann; Carolin Jenkner; Sabina Millenet; Marcel Romanos Journal: Trials Date: 2018-04-27 Impact factor: 2.279
Authors: Christopher Hautmann; Manfred Döpfner; Josepha Katzmann; Stephanie Schürmann; Tanja Wolff Metternich-Kaizman; Charlotte Jaite; Viola Kappel; Julia Geissler; Andreas Warnke; Christian Jacob; Klaus Hennighausen; Barbara Haack-Dees; Katja Schneider-Momm; Alexandra Philipsen; Swantje Matthies; Michael Rösler; Wolfgang Retz; Alexander von Gontard; Esther Sobanski; Barbara Alm; Sarah Hohmann; Alexander Häge; Luise Poustka; Michael Colla; Laura Gentschow; Christine M Freitag; Katja Becker; Thomas Jans Journal: BMC Psychiatry Date: 2018-12-13 Impact factor: 3.630